---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-026040"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2025-08-29T23:59:59+00:00"
generated_at: "2026-05-17T09:21:57.878465+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences receives Nasdaq deficiency notice for failing minimum equity requirement

## Summary
- Nasdaq notified Enveric on Aug 26, 2025 that stockholders' equity of $2.18M as of June 30, 2025 is below $2.5M minimum.
- Company has until Oct 10, 2025 to submit a plan to regain compliance; Nasdaq may grant a 180-day extension if plan is accepted.
- If plan is rejected, Company may appeal to a Nasdaq Hearings Panel.
- Company intends to submit a compliance plan and consider available options to regain compliance.

## SEC filing metadata
- accession: 0001641172-25-026040
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2025-08-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000164117225026040/0001641172-25-026040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000164117225026040/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-026040
- JSON: https://secwatch.observer/filing/0001641172-25-026040.json
- Plain text: https://secwatch.observer/filing/0001641172-25-026040.txt

## Key facts
- Listing & Compliance Notices
  Enveric Biosciences, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: August 26, 2025, Enveric Biosciences, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on the Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000 (the “Stockholders’Equity Requirement”). The Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2025, r
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000164117225026040/0001641172-25-026040-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.